TABLE 2.
Antibiotic susceptibility and MIC of bacteria a
| Bacterial strains | Antibiotics | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMI | P/T4 | TGC | TIM2 | LEVO | NIT | TET | DOR | MIN | ETP | SXT | IMI | PIP | MERO | GEN | FAZ | TOB | TAZ | A/S2 | AZT | AMP | FEP | CIP | AXO | |
| KPN 270 | 8 S | 128/4 R |
1 S |
64/2 R |
8 R |
64 R |
8 I |
4 R |
8 I |
8 R |
4/76 R |
8 R |
64 R |
8 R |
2 S |
16 R |
2 S |
16 R |
16/8 R |
16 R |
16 R |
32 R |
2 R |
32 R |
| KPN U2874R | 8 S | 128/4 R |
1 S |
64/2 R |
4 S |
64 R |
4 S |
4 R |
4 S |
8 R |
4/76 R |
8 R |
64 R |
8 R |
2 S |
16 R |
2 S |
16 R |
16/8 R |
16 R |
16 R |
32 R |
2 R |
32 R |
| KPN H2R | 8 S | 128/4 R |
1 S |
64/2 R |
4 S |
64 R |
4 S |
4 R |
4 S |
8 R |
4/76 R |
8 R |
64 R |
8 R |
2 S |
16 R |
2 S |
16 R |
16/8 R |
16 R |
16 R |
32 R |
2 R |
32 R |
| KPN S3R | 8 S | 128/4 R |
1 S |
64/2 R |
4 S |
64 R |
4 S |
4 R |
4 S |
8 R |
4/76 R |
8 R |
64 R |
8 R |
2 S |
16 R |
2 S |
16 R |
16/8 R |
16 R |
16 R |
32 R |
2 R |
32 R |
a
AMI: amikacin, P/T4: piperacillin/tazobactam constant 4, TGC: tigecycline, TIM2: ticarcillin/clavulanic acid constant 2, LEVO: levofloxacin, NIT: nitrofurantoin, TET: tetracycline, DOR: doripenem, MIN: minocycline, PIP: piperacillin, MERO: meropenem, GEN: gentamycin, FAZ: cefazolin, TOB: tobramycin, TAZ: ceftazidime, A/S2: ampicillin/sulbactam, AZT: aztreonam, AMP: ampicillin, FEP: cefepime, CIP: ciprofloxacin, AXO: ceftriaxone; S: susceptible, I: intermediate, R: resistance; number: minimal inhibitory concentration (MIC).